Sorafenib, a multikinase inhibitor, enhances the response of melanoma to regional chemotherapy
Christina K. Augustine, Hiroaki Toshimitsu, Sin Ho Jung, Patricia A. Zipfel, Jin S. Yoo, Yasunori Yoshimoto, M. Angelica Selim, James Burchette, Georgia M. Beasley, Nicole McMahon, James Padussis, Scott K. Pruitt, Francis Ali-Osman, Douglas S. Tyler
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'Sorafenib, a multikinase inhibitor, enhances the response of melanoma to regional chemotherapy'. Together they form a unique fingerprint.